1. Bridge, J. A., Bhatia, P. S., Anderson, J. R., & Neff, J. R. (1993). Biologic and clinical significance of cytogenetic and molecular cytogenetic abnormalities in benign and malignant cartilaginous lesions. Cancer Genetics and Cytogenetics, 69, 79–90.
2. Dahlén, A., Mertens, F., Rydholm, A., Brosjö, O., Wejde, J., Mandahl, N., & Panagopoulos, I. (2003). Fusion, disruption, and expression of HMGA2 in bone and soft tissue chondromas. Modern Pathology, 16, 1132–1140.
3. Goldblum, J. R., Folpe, A. L., & Weiss, S. W. (2014). Cartilaginous and osseous soft tissue tumors. In J. R. Goldblum, A. L. Folpe, & S. W. Weiss (Eds.), Enzinger and Weiss’s soft tissue tumors (pp. 918–922). Philadelphia: Elsevier Saunders.
4. Macchiarini, P., & Ostertag, H. (2004). Uncommon primary mediastinal tumours. Lancet Oncology, 5, 107–118.
5. Rosenberg, A. E., & Mandahl, N. (2013). Soft-tissue chondroma. In C. D. M. Fletcher, J. A. Bridge, P. C. W. Hogendoorn, & F. Mertens (Eds.), WHO classification of tumours of soft tissue and bone (pp. 160–161). Lyon: International Agency for Research on Cancer.